Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
about
Mucosal resident memory CD4 T cells in protection and immunopathologyIdentification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected SubjectsAsymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein BCD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins.Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesContrasting roles for TLR ligands in HIV-1 pathogenesis.Herpes simplex virus type 2 vaccines: new ground for optimism?Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans.Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmissionRecent progress in herpes simplex virus immunobiology and vaccine researchExpression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.Homing in on the cellular immune response to HSV-2 in humans.Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infectionVirus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 diseaseEffects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.Human CD4+ CD25 high cells suppress proliferative memory lymphocyte responses to herpes simplex virus type 2.Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitisSingle and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal modelsMerkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study.Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individualsDiscovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeHigh frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpesA Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensZoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus.Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in femalesPeripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes.HLA-DQB1 codon 57 is critical for peptide binding and recognition.Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alphaCurrent trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responsesExtensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptorAn adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.
P2860
Q26823137-C0660CB8-399C-47BA-9BDC-9B4BBD3CEF08Q27303136-6A9762C4-F734-4FD1-9EE8-A5F69B25FF92Q27486108-CF4D7C18-11EA-4183-B2E2-F415061256FCQ30847945-C5D9B2A9-B528-42CA-9B00-05C1C89FAD07Q30957753-CE8875BD-ED4A-4AA4-8E6D-3E0472F41B92Q33248961-640A9D94-41A5-49B4-BAF5-3A3F2ECBC60FQ33700312-0B1CA4EB-2F6F-4F2E-8462-1FC4437DEACDQ33711912-55F0DEEB-5031-4671-BD36-CA55280BD309Q33824488-74608D72-F0CF-455E-A86D-93BB31E951F8Q33826410-F454E8EA-3F8E-4D68-BE7D-AE1BA30AEA1EQ33850188-2EA3D12B-612B-4CE4-A14F-87AC70BDCCFAQ33963713-A4B18242-7E61-436D-80CC-441BCD5FD014Q34081662-9A28154D-6748-4EF8-852B-C6855A42974FQ34081670-BC7E4DBD-3E62-4A6E-87C8-54A22875CD97Q34470969-820C714A-BB9A-4034-A657-171F966991C1Q34653920-0488FB23-B9BE-4C7A-BF1E-65BE9FE0A236Q34742583-C612C14A-C7D5-4A4F-A1A7-35A07FA7F255Q34856138-117E9EA8-DF56-4545-BCB4-A80FDF0023E0Q35024021-0D44EC47-00F4-4D97-9376-EFF2BF13AEC0Q35066312-15BCFF04-475F-4C27-AD56-DEEE9D583679Q35271194-8F8F49C2-2740-43C5-B86F-A98D91FA3354Q35510910-92962C24-CE96-4970-B14F-0A48B72A0131Q35699002-2E88E794-1FEB-4CCE-A631-24B53E6079E0Q35763313-5621071E-FE93-4350-9BD5-64EF4AEADD29Q35868029-2B7A1602-40EA-4726-A3F1-D3CE95553961Q35868054-FCB04296-08FC-4965-8D66-D0D7CDB47896Q35871689-8CDB35DF-1AE6-4AF4-A6D3-44CAF39E5EB6Q35872807-C9E46331-34EE-48FC-9BE2-811F63AC2C9EQ35914367-47032932-96E7-41EA-AE27-A73B258D8AFEQ36024466-BE6C2431-9F79-4CA0-9E3F-508D9DBADBB7Q36173112-BDE42824-5E29-4629-9055-670894C20329Q36246306-87C7FF06-FAC9-40D6-8BA4-5DE8A09C9CB7Q36365882-41EE89C2-1BDE-4EF8-ABF7-81FC3FA30CECQ36403830-A4C5ED1D-38B1-41DC-9CDA-28678ECF064CQ36555158-1D894BA1-F08E-4A88-8534-FC1A344B2F43Q36585733-142C6B14-550D-49A8-9F4D-373A87FE4C70Q36601101-5C0F5413-FA05-4EF3-A0C9-04EDDF529F47Q36689912-31596B2D-1E84-4A77-80C0-B6C9C8B3CCD3Q36759693-3502EE07-1AB2-4F82-B26A-46C41537C037Q36898071-EE793078-8EE6-448A-8BFC-64BE2BEA060D
P2860
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Antigenic specificities of hum ...... simplex virus type 2 lesions.
@ast
Antigenic specificities of hum ...... simplex virus type 2 lesions.
@en
type
label
Antigenic specificities of hum ...... simplex virus type 2 lesions.
@ast
Antigenic specificities of hum ...... simplex virus type 2 lesions.
@en
prefLabel
Antigenic specificities of hum ...... simplex virus type 2 lesions.
@ast
Antigenic specificities of hum ...... simplex virus type 2 lesions.
@en
P2093
P2860
P1433
P1476
Antigenic specificities of hum ...... s simplex virus type 2 lesions
@en
P2093
R J Eisenberg
R Pichyangkura
S J Triezenberg
P2860
P304
P407
P577
1994-05-01T00:00:00Z